Prevalence of type 1 diabetes autoantibodies (GADA, IA2, and IAA) in overweight and obese children

Diabetes Care

Volumn 33, Issue 4, 2010, Pages 820-822

  Cambuli, Valentina M ^a   Incani, Michela ^a   Cossu, Efisio ^a   Congiu, Tiziana ^a   Scano, Francesca ^a   Pilia, Sabrina ^b   Sentinelli, Federica ^a   Tiberti, Claudio ^c   Cavallo, M Gisella ^c   Loche, Sandro ^b   Baroni, Marco G ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Osp Regionale per le Microcitemie   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DECARBOXYLASE 65 ANTIBODY; INSULIN ANTIBODY;

ARTICLE; BODY WEIGHT; CHILD; CORRELATION ANALYSIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE;

ADOLESCENT; AUTOANTIBODIES; AUTOANTIGENS; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; OBESITY; OVERWEIGHT; PREVALENCE;

EID: 77953079073     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-1573     Document Type: Article

References (12)

1. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltéthe EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009;373:2027-2033
2. Hyppönen E, Virtanen SM, Kenward MG, Knip M, Åkerblom HK, the Childhood Diabetes in Finland Study Group. Obesity, increased linear growth, and risk of type I diabetes in children. Diabetes Care 2000;23:1755-1760
3. Wilkin TJ. The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes. Int J Obes (Lond) 2009;33:716-726
4. Dabelea D, D'Agostino RB Jr, Mayer-Davis EJ, Pettitt DJ, Imperatore G, Dolan LM, Pihoker C, Hillier TA, Marcovina SM, Linder B, Ruggiero AM, Hamman RF. SEARCH for Diabetes in Youth Study Group: Testing the accelerator hypothesis: body size, beta-cell function, and age at onset of type 1 (autoimmune) diabetes. Diabetes Care 2006;29:1462-1463
5. Casu A, Pascutto C, Bernardinelli L, Songini M, the Sardinian IDDM Epidemiology Study Group. Type 1 diabetes among Sardinian children is increasing: the Sardinian Diabetes register 0-14 years, 1989-1999. Diabetes Care 2004;27:1623-1629
6. Marras V, Macchis R, Foschini ML, Pilia S, Sortino M, Tilocca S, Casini MR, Porcu M, Faedda A, Loche S. Prevalence of overweight and obesity in primary school children in Southern Sardinia, Italy. Ital J Pediatr 2006;32:251-255
7. Vardi P, Dib SA, Tuttleman M, Connelly JE, Grinbergs M, Radizabeh A, Riley WJ, Maclaren NK, Eisenbarth GS, Soeldner JS. Competitive insulin autoantibody assay: prospective evaluation of subjects at high risk for development of type I diabetes mellitus. Diabetes 1987;36:1286-1291 (Pubitemid 17163989)
8. Schlosser M, Strebelow M, Wassmuth R, Arnold ML, Breunig I, Rjasanowski I, Ziegler B, Ziegler M. The Karlsburg Type 1 Diabetes Risk Study of a normal school-child population: association of beta-cell autoantibodies and human leukocyte antigen-DQB1 alleles in antibody-positive individuals. J Clin Endocrinol Metab 2002;87:2254-2261
9. Locatelli M, Songini M, Bottazzo GF. IDDM-Sardinia Project: a study model on the etiopathogenesis of insulin-dependent diabetes mellitus and other autoimmune pathologies. Gruppi di studio IDDM-Sardegna. Ann Ist Super Sanita 1999;35:253-263
10. Lorini R, Alibrandi A, Vitali L, Klersy C, Martinetti M, Betterle C, d'Annunzio G, Bonifacio E, Pediatric Italian Study Group of Prediabetes. Risk of type 1 diabetes development in children with incidental hyperglycemia: a multicenter Italian study. Diabetes Care 2001;24:1210-1216
11. Triolo DM, Chase HP, Barker JM, the DPT-1 Study Group. Diabetes subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset. Diabetes Care 2009;32:769-773
12. Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L, Cerutti F, Gargantini L, Greggio N, Tonini G, Cicognani A. Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest 2006;29:581-593 (Pubitemid 44446267)